Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Trial: Protocol for a Randomized, Controlled, Multicenter Study Comparing the Solitaire Revascularization Device with IV tPA with IV tPA Alone in Acute Ischemic Stroke
Jeffrey L. Saver(University of California, Los Angeles), Demetrius K. Lopes(Aurora Health Care), Tudor G. Jovin(Cooper University Hospital), Dileep R. Yavagal(Jackson Health System), Olav Jansen(University Hospital Schleswig-Holstein), Gregory W. Albers(Stanford University), Elad I. Levy(Kaleida Health), Heinrich P. Mattle(University of Bern), Adnan H. Siddiqui(Jacobs (United States)), Raul G. Nogueira(UPMC Health System), Mayank Goyal(University of Calgary), Werner Hacke(Heidelberg University), Vítor Mendes Pereira(St. Michael's Hospital), Thomas Devlin, Christophe Cognard(Hôpital Purpan), Reza Jahan(University of California, Los Angeles), Hans‐Christoph Diener(Essen University Hospital), Richard du Mesnil de Rochemont(Institute of Neurobiology), Alain Bonafé, Vivek Reddy(University of Pittsburgh Medical Center)
Cited by 278
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k